Guizhou Yibai Pharmaceutical Co (SHSE:600594) YoY EBITDA Growth : 96.05% (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Guizhou Yibai Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Guizhou Yibai Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 96.05%.

Guizhou Yibai Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥-0.00.

Guizhou Yibai Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Guizhou Yibai Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Yibai Pharmaceutical Co YoY EBITDA Growth Chart

Guizhou Yibai Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

16.31

3.30

-134.82

306.42

-132.00

Guizhou Yibai Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															-211.76	-136.09	-209.38	-180.00	96.05

Guizhou Yibai Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Guizhou Yibai Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-0.144	-	0.45)	/	\| 0.45 \|
=	-132.00 %

Guizhou Yibai Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(-0.003	-	-0.076)	/	\| -0.076 \|
=	96.05 %

Guizhou Yibai Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Guizhou Yibai Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Yibai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Yibai Pharmaceutical Co Ltd (SHSE:600594) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

No. 220-1 Baiyun Avenue, Guiyang, Guizhou, CHN, 550008

Website

http://www.gzcci.com

Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.

Executives

Dou Qi Ling	Director
Gan Ning	Director
Lang Hong Ping	Director
Xia Xiao Hui	senior management
Dou Ya Qi	Director
Wang Zhi Wei	Director
Zhu Yue Xing	Director
Dai Yuan Fu	senior management
Zhang Sheng Gui	senior management
Feng Zhi Gang	senior management
Yue Wei	Director
Liu Hua	Supervisors
Ye Xiang Wu	Director
Jian Wei Guang	Director

Guizhou Yibai Pharmaceutical Co Headlines

No Headlines